Share on StockTwits

Vitamin Shoppe (NYSE:VSI) was downgraded by Zacks from a “neutral” rating to an “underperform” rating in a research note issued on Thursday. They currently have a $37.90 price objective on the stock. Zacks‘s price objective points to a potential downside of 4.92% from the stock’s previous close.

A number of other analysts have also recently weighed in on VSI. Analysts at Deutsche Bank reiterated a “buy” rating on shares of Vitamin Shoppe in a research note on Wednesday, August 6th. They now have a $50.00 price target on the stock, down previously from $55.00. Separately, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Vitamin Shoppe in a research note on Wednesday, August 6th. They now have a $49.00 price target on the stock, down previously from $54.00. Finally, analysts at Longbow Research reiterated a “buy” rating on shares of Vitamin Shoppe in a research note on Wednesday, August 6th. They now have a $55.00 price target on the stock, down previously from $59.00. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $49.32.

Vitamin Shoppe (NYSE:VSI) traded up 0.08% on Thursday, hitting $39.89. 448,451 shares of the company’s stock traded hands. Vitamin Shoppe has a 1-year low of $36.90 and a 1-year high of $55.20. The stock has a 50-day moving average of $40.97 and a 200-day moving average of $43.86. The company has a market cap of $1.217 billion and a price-to-earnings ratio of 18.78.

Vitamin Shoppe (NYSE:VSI) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.62 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.63 by $0.01. The company had revenue of $306.20 million for the quarter, compared to the consensus estimate of $306.09 million. During the same quarter in the prior year, the company posted $0.60 earnings per share. The company’s quarterly revenue was up 9.6% on a year-over-year basis. Analysts expect that Vitamin Shoppe will post $2.27 EPS for the current fiscal year.

Vitamin Shoppe, Inc is a specialty retailer and direct marketer of vitamins, minerals, herbs, specialty supplements, sports nutrition and other health and wellness products.

To view Zacks’ full report, visit Zacks’ official website.

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.